ORPHAZYME A/S

ORPHA
Delayed Quote. Delayed  - 11/26 10:59:57 am
22.28DKK -4.79%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 2 328779
Entreprise Value (EV)1 1 668657
P/E ratio -3,01x-1,45x
Yield --
Capitalization / Revenue -32,0x
EV / Revenue -27,0x
EV / EBITDA -2,77x-0,97x
Price to Book 3,75x8,88x
Nbr of stocks (in thousands) 34 69834 952
Reference price (DKK) 67,122,3
Announcement Date 03/02/2021-
Previous period Next period
1 DKK in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 -24,4
EBITDA1 -603-674
Operating profit (EBIT)1 -609-689
Operating Margin --2 831%
Pre-Tax Profit (EBT)1 -635-695
Net income1 -633-634
Net margin --2 603%
EPS2 -22,3-15,4
Dividend per Share --
Announcement Date 03/02/2021-
Previous period Next period
1 DKK in Million
2 DKK
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 --
Net Cash position1 660122
Leverage (Debt / EBITDA) 1,09x0,18x
Free Cash Flow1 -544-605
ROE (Net Profit / Equities) -188%-151%
Shareholders' equity1 337420
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share2 17,92,51
Cash Flow per Share2 -19,0-17,1
Capex1 5,1010,2
Capex / Sales -41,9%
Announcement Date 03/02/2021-
Previous period Next period
1 DKK in Million
2 DKK
Financial Ratios
Size 2021e 2022e
Capitalization 779 M DKK -
Entreprise Value (EV) 657 M DKK 903 M DKK
Valuation 2021e 2022e
P/E ratio (Price / EPS) -1,45x -4,33x
Capitalization / Revenue 32,0x 21,6x
EV / Revenue 27,0x 18,2x
EV / EBITDA -0,97x -1,98x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 8,88x -8,47x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) -2 831% -814%
Operating Leverage (Delta EBIT / Delta Sales) - 1,19x
Net Margin (Net Profit / Revenue) -2 603% -811%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -151% -
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   41,9% 42,4%
Cash Flow / Sales -2 454% -648%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -0,37x
EPS & Dividend